AMTI Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 des 2023 @ 21:59):

Stats
Dagens volum	235 210
Gjennomsnittsvolum	320 195
Markedsverdi	11.01M
EPS	$0 ( 2024-03-14 )
Neste inntjeningsdato	( $0 ) 2024-05-09
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.139
ATR14	$0.0200 (7.60%)

Insider Trading

Date	Person	Action	Amount	type
2023-12-27	Epiq Capital Group, Llc	Sell	2 149 292	Common Stock
2023-12-27	Epiq Capital Group, Llc	Sell	3 394 948	Common Stock
2023-12-27	Epiq Capital Group, Llc	Sell	2 500 000	Common Stock
2023-12-27	Epiq Capital Group, Llc	Sell	293 278	Common Stock
2023-12-27	Vandevender Aaron	Sell	212 659	Common Stock

INSIDER POWER
-68.14
Last 100 transactions
Buy: 3 477 833 \| Sell: 13 394 035

Volum Korrelasjon

Lang: 0.02 (neutral)

Kort: 0.79 (moderate)

Signal:(62.898) Neutral

Applied Molecular Korrelasjon

10 Mest positive korrelasjoner
WOOF	0.969
WKEY	0.967
JAN	0.961
NMRD	0.96
MTLS	0.958
PODD	0.957
QRTEA	0.956
STIM	0.956
GERN	0.955
ENNV	0.955

10 Mest negative korrelasjoner
IGTA	-0.965
NVCN	-0.953
OHAA	-0.952
LCA	-0.951
TIOA	-0.949
BRIVU	-0.949
FTII	-0.949
HDSN	-0.948
MSDA	-0.946
CBRG	-0.941

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Applied Molecular Korrelasjon - Valuta/Råvare

0.84
( strong )

0.32
( neutral )

0.00
( neutral )

0.67
( moderate )

-0.25
( neutral )

-0.86
( strong negative )

Applied Molecular Økonomi

Annual	2022
Omsetning:	$0
Bruttogevinst:	$0 (0.00 %)
EPS:	$-3.23

FY	2022
Omsetning:	$0
Bruttogevinst:	$0 (0.00 %)
EPS:	$-3.23

FY	2021
Omsetning:	$0.00
Bruttogevinst:	$0.00 (0.00 %)
EPS:	$-4.38

FY	2020
Omsetning:	$0.00
Bruttogevinst:	$0.00 (0.00 %)
EPS:	$-2.91

Financial Reports:

No articles found.

Applied Molecular

Applied Molecular Transport Inc., a clinical-stage biopharmaceutical company, engages in the design and development of a pipeline of oral and respiratory biologic product candidates to treat autoimmune, inflammatory, metabolic, and other diseases. The company's lead product candidate is AMT-101, a gastrointestinal (GI) selective oral fusion of rhIL-10 that is in Phase II clinical trial for the treatment of ulcerative colitis and related inflammatory indications. It develops AMT-126, a GI-selective oral fusion of interleukin 22, which is in a Phase I clinical trial for diseases related to intestinal epithelium barrier function defects. The company, through its technology platform, designs and develops various oral biologic therapeutic modalities, such as peptides, proteins, antibodies, antibody fragments, and ribonucleic acid therapeutics. Applied Molecular Transport Inc. was founded in 2010 and is headquartered in South San Francisco, California.